Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Contaminated Drug Ingredients at Ireland Plant

The U.S. Food and Drug Administration (FDA) issued a warning letter to GlaxoSmithKline regarding the company’s corrective actions in response to findings of contamination at its manufacturing plant in Cork, Ireland. The FDA found that GSK did not fully investigate a list of violations found during an FDA inspection of the plant in October 2013, and that the company did not notify the public when some batches of a drug or drugs containing a contaminated ingredient were shipped.

Misconduct Type
Health
Enforcement Agency
Health and Human Services
Contracting Party
None
Court Type
Administrative
Disposition
Investigative Finding
Date of Warning Letter
3/18/2014
Contractors Involved Penalty
Total
GlaxoSmithKline $0
Further Information Released
FDA Warning Letter 3/18/2014

Federal Contractor Misconduct Database